AGP Picks
View all

Illinois Tech Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Illinois Tech Journal.

Press releases published on November 3, 2026

Sprout Social Announces Third Quarter 2026 Financial Results
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Astera Labs Reports Third Quarter 2026 Financial Results
Tarsus Reports Third Quarter 2026 Financial Results
Varonis Announces Third Quarter 2026 Financial Results
TTEC Schedules Third Quarter 2026 Earnings Release and Webcast of Investor Conference Call
Mineralys Therapeutics to Participate in Upcoming Investor Conferences
BNB Standard Corporation Appoints Anthony Scaramucci to Its Board of Directors
MacroGenics Announces Appointments of Emil Kuriakose, M.D., and Michael Vasconcelles, M.D., to Board of Directors
Aura Biosciences to Participate in Upcoming Investor Conference
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Spyre Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Nurix Therapeutics Announces Sanofi’s Decision to Discontinue Development of STAT6 Degrader SAR448272
Monte Rosa Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ardelyx Reports Third Quarter 2026 Financial Results and Provides Business Update
Key Tronic Corporation Announces Results for the First Quarter of Fiscal 2027
Denali Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights
Aquestive Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
QSIC Appoints Former Woolworths and Cartology Leader Mark Mansour as Managing Director APAC
DeepInfra Expands Startup Support Through NVIDIA Inception Offering

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Illinois Tech Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.